Trials / Completed
CompletedNCT01750723
Acetazolamide's Headache Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow
Basic Research on Acetazolamide´s Headache Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow in a Humane Experimental Headache Model
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Danish Headache Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
In this study the investigators will research the hypothesis that the drug Acetazolamide induce headache and dilation of cerebral arteries and increase the cerebral blood flow in the areas of the brain supplied by these arteries.
Detailed description
To investigate headache score and accompanying symptoms during and after infusion of acetazolamide. With magnetic resonance imaging the investigators will investigate changes in regional cerebral blood flow (rCBF) in the area supplied by middle cerebral artery (MCA), diameter of MCA, the Internal carotic artery (ICA), the superficial temporal artery (STA) and the Medial Meningeal artery (MMA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acetazolamide | 1 g diluted in 10 ml saline, i.v. bolus injection. |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2012-12-17
- Last updated
- 2013-07-09
Locations
2 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01750723. Inclusion in this directory is not an endorsement.